TY  - GEN
AU  - Jonsson,Malin K B
AU  - Vos,Marc A
AU  - Mirams,Gary R
AU  - Duker,Göran
AU  - Sartipy,Peter
AU  - de Boer,Teun P
AU  - van Veen,Toon A B
TI  - Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG
SN  - 1095-8584
PY  - 2012///0807
KW  - 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
KW  - pharmacology
KW  - Action Potentials
KW  - Arrhythmias, Cardiac
KW  - drug therapy
KW  - Benzazepines
KW  - Calcium Channel Agonists
KW  - Calcium Channel Blockers
KW  - Calcium Signaling
KW  - Cells, Cultured
KW  - Cisapride
KW  - Drug Evaluation, Preclinical
KW  - ERG1 Potassium Channel
KW  - Embryonic Stem Cells
KW  - physiology
KW  - Ether-A-Go-Go Potassium Channels
KW  - antagonists & inhibitors
KW  - Humans
KW  - Myocytes, Cardiac
KW  - drug effects
KW  - Nifedipine
KW  - Patch-Clamp Techniques
KW  - Sodium Channels
KW  - metabolism
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.yjmcc.2012.02.002
ER  -